Comments

Rapport Therapeutics Insider Trading Activity

RAPPNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$29.69

-0.58-1.92%

Last update: Dec 15, 2:03 PM

Overview News Earnings Options Analyst Ratings

Insider Trades

Short Interest Stock Report

Rapport Therapeutics Insider Trading Activity | NASDAQ:RAPP | Benzinga

Track the latest Rapport Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Rapport Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Rapport Therapeutics Inc Insiders Doing?

At Rapport Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 19.42K shares worth $489.14K, meanwhile, insiders have report no purchases in the last 30 days.

Notable Recent Insider Buys and Sales

On September 17, 2025, David Bredt, the company's CHIEF SCIENTIFIC OFFICER sold 8.5K shares for $24.19 each.
On November 18, 2025, David Bredt, the company's CHIEF SCIENTIFIC OFFICER sold 8.5K shares for $25.19 each.
On October 16, 2025, David Bredt, the company's CHIEF SCIENTIFIC OFFICER sold 8.5K shares for $25.79 each.

Ownership Statistics for Rapport Therapeutics Inc

Shares Outstanding

47.661M

Insider Shares Owned

2.153M

Insider Percentage Owned

4.52%

Institutional Shares Held

20.075M

Institutional Percentage Held

42.1%


Dec 01, 2025	Cheryl Gault	CHIEF OPERATING OFFICER	0.00	$15.95	-$141.49K	SELL-OPTIONS	0.00%	171.93K	Nov 26	View
Nov 18, 2025	Abraham Ceesay	CHIEF EXECUTIVE OFFICER	-10.92K	$25.20	-$275.05K	SELL	-8.49%	117.71K	Nov 17	View
Nov 18, 2025	David Bredt	CHIEF SCIENTIFIC OFFICER	-8.50K	$25.19	-$214.09K	SELL	-2.07%	401.14K	Nov 17	View
Oct 16, 2025	David Bredt	CHIEF SCIENTIFIC OFFICER	-8.50K	$25.79	-$219.20K	SELL	-2.03%	409.64K	Oct 15	View
Oct 16, 2025	Abraham Ceesay	CHIEF EXECUTIVE OFFICER	-10.92K	$25.81	-$281.73K	SELL	-8.16%	122.79K	Oct 15	View
Sep 19, 2025	Abraham Ceesay	CHIEF EXECUTIVE OFFICER	-76.42K	$26.32	-$2.01M	SELL	-37.41%	127.87K	Sep 17	View
Sep 17, 2025	David Bredt	CHIEF SCIENTIFIC OFFICER	-8.50K	$24.19	-$205.65K	SELL	-1.99%	418.14K	Sep 15	View
Sep 15, 2025	Reid Huber	—	20.40K	$24.48	$499.37K	BUY	∞	20.40K	Sep 12	View
Sep 15, 2025	STEVEN PAUL	—	41.67K	$24.65	$1.03M	BUY	∞	41.67K	Sep 12	View
Sep 11, 2025	Wendy Young	—	3.50K	$22.60	$79.10K	BUY	58.33%	9.50K	Sep 11	View
Sep 10, 2025	Cheryl Gault	CHIEF OPERATING OFFICER	0.00	$20.06	-$182.65K	SELL-OPTIONS	0.00%	171.93K	Sep 08	View
Aug 18, 2025	David Bredt	CHIEF SCIENTIFIC OFFICER	-8.50K	$15.00	-$127.47K	SELL	-1.95%	426.64K	Aug 15	View
Jul 16, 2025	David Bredt	CHIEF SCIENTIFIC OFFICER	-8.50K	$14.00	-$118.96K	SELL	-1.92%	435.14K	Jul 15	View
Jun 18, 2025	David Bredt	CHIEF SCIENTIFIC OFFICER	-8.50K	$11.00	-$93.52K	SELL	-1.88%	443.64K	Jun 16	View
May 19, 2025	David Bredt	CHIEF SCIENTIFIC OFFICER	-8.50K	$9.56	-$81.26K	SELL	-1.85%	452.14K	May 15	View
Apr 16, 2025	David Bredt	CHIEF SCIENTIFIC OFFICER	-8.50K	$9.57	-$81.31K	SELL	-1.81%	460.64K	Apr 15	View
Mar 17, 2025	David Bredt	CHIEF SCIENTIFIC OFFICER	-8.50K	$10.85	-$92.21K	SELL	-1.78%	469.14K	Mar 14	View
Mar 13, 2025	Troy Ignelzi	CHIEF FINANCIAL OFFICER	10.00K	$10.10	$100.99K	BUY	∞	10.00K	Mar 12 - Mar 13	View
Mar 13, 2025	Wendy Young	—	6.00K	$10.21	$61.25K	BUY	∞	6.00K	Mar 12	View
Jul 03, 2024	JAMES HEALY	DIRECTOR	44.03K	$24.52	$1.08M	BUY	284.81%	59.49K	Jul 01	View
Jun 10, 2024	JAMES HEALY	—	1.95M	$17.00	$9.50M	BUY	∞	25.45K	Jun 10	View

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.